UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 63

Sortiert nach

OC.03.2 ASSOCIATION OF VITAMIN D SERUM LEVELS AND ITS COMMON GENETIC DETERMINANTS, WITH SEVERITY OF LIVER FIBROSIS IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

Digestive and liver disease, 2013-03, Vol.45, p.S62-S63

2013

Volltextzugriff (PDF)

OC.06.4: The Addition of an Immunosuppressant is an Effective Optimization Strategy after Loss of Response to Anti-Tnf Alpha Monotherapy in Patients with Inflammatory Bowel Disease: A Two-Year Experience

Digestive and liver disease, 2017-03, Vol.49, p.e92-e92

2017

Volltextzugriff (PDF)

OC.06.5: Mycophenolate Mofetil is a Valid Option in Patients with Inflammatory Bowel Disease Resistant to TNF-Alpha Inhibitors and Conventional Immunosuppressants

Digestive and liver disease, 2017-03, Vol.49, p.e92-e93

2017

Volltextzugriff (PDF)

P.11.3: Poor Tolerability Profile of Thiopurines in Inflammatory Bowel Disease: A Prospective Single-Centre Experience

Digestive and liver disease, 2017-03, Vol.49, p.e203-e203

2017

Volltextzugriff (PDF)

P.11.15: The Long Term Course of Patients Undergoing Ileal Pouch-Anal Anastomosis for Ulcerative Colitis

Digestive and liver disease, 2017-03, Vol.49, p.e208-e208

2017

Volltextzugriff (PDF)

P768 PNPLA3 rs738409 C>G SNP IS ASSOCIATED WITH HISTOLOGICAL FEATURES OF NASH IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S326-S326

2014

Volltextzugriff (PDF)

P1009 THE HISTOLOGICAL OR ULTRASONOGRAPHIC DETECTION OF STEATOSIS AFFECTS THE PERFORMANCE OF LIVER STIFFNESS MEASUREMENT FOR FIBROSIS ASSESSMENT IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 INFECTION

Journal of hepatology, 2014-04, Vol.60 (1), p.S411-S411

2014

Volltextzugriff (PDF)

P0760 : PNPLA3 rs738409 I748M is associated with steatohepatitis in non obese subjects with hepatitis C

Journal of hepatology, 2015-04, Vol.62, p.S614-S614

2015

Volltextzugriff (PDF)

OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety

Digestive and liver disease, 2017-03, Vol.49, p.e91-e91

2017

Volltextzugriff (PDF)

473 ASSOCIATION OF VITAMIN D SERUM LEVELS AND ITS COMMON GENETIC DETERMINANTS, WITH SEVERITY OF LIVER FIBROSIS IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

Journal of hepatology, 2013-04, Vol.58, p.S194-S194

2013

Volltextzugriff (PDF)

486 INDUSTRIAL, BUT NOT FRUIT FRUCTOSE INTAKE IS INDEPENDENTLY ASSOCIATED WITH SEVERE LIVER FIBROSIS IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

Journal of hepatology, 2013-04, Vol.58, p.S199-S199

2013

Volltextzugriff (PDF)

PNPLA3 RS738409 I748 M is associated with steatohepatitis in non obese subjects with hepatitis C

Digestive and liver disease, 2015-02, Vol.47, p.e27-e27

2015

Volltextzugriff (PDF)

The histological or ultrasonographic detection of steatosis affects the performance of LSM in patients with chronic HCV genotype 1 infection

Digestive and liver disease, 2014-02, Vol.46, p.e20-e20

2014

Volltextzugriff (PDF)

PNPLA3 rs738409 C > G SNP is associated with histological features of NASH in genotype 1 chronic hepatitis C patients

Digestive and liver disease, 2014-02, Vol.46, p.e19-e19

2014

Volltextzugriff (PDF)

918 HIGH SCD36 PLASMA LEVEL IS ASSOCIATED WITH STEATOSIS AND ITS SEVERITY IN PATIENTS WITH CHRONIC GENOTYPE 1 HEPATITIS C

Journal of hepatology, 2012-04, Vol.56, p.S357-S358

2012

Volltextzugriff (PDF)

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

Digestive and liver disease, 2013-10, Vol.45, p.e371-e371

2013

Volltextzugriff (PDF)

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

Digestive and liver disease, 2013-10, Vol.45, p.e370-e370

2013

Volltextzugriff (PDF)

P.18.10 IL28-B POLYMORPHISMS AND NATURAL HISTORY OF PRIMARY BILIARY CIRRHOSIS

Digestive and liver disease, 2013-03, Vol.45, p.S213-S213

2013

Volltextzugriff (PDF)

P.03.7 CLINICAL COURSE AND PROGNOSTIC FACTORS OF HEPATORENAL SYNDROME: THE IMPACT OF VASOACTIVE DRUGS

Digestive and liver disease, 2012-03, Vol.44, p.S101-S101

2012

Volltextzugriff (PDF)

P.03.15 NATURAL HISTORY OF PRIMARY BILIARY CIRRHOSIS: EXPERIENCE FROM SINGLE CENTER IN SOUTHERN ITALY

Digestive and liver disease, 2012-03, Vol.44, p.S104-S104

2012

Volltextzugriff (PDF)

T-03 Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients

Digestive and liver disease, 2013-02, Vol.45, p.S13-S14

2013

Volltextzugriff (PDF)

F-06 Industrial, but not fruit fructose intake is independently associated with severe liver fibrosis in genotype 1 chronic hepatitis C patients

Digestive and liver disease, 2013-02, Vol.45, p.S33-S33

2013

Volltextzugriff (PDF)

T-18 Natural history of primary biliary cirrhosis: experience from a single center in southern Italy

Digestive and liver disease, 2012-02, Vol.44, p.S19-S20

2012

Volltextzugriff (PDF)

OC-34 Clinical features and outcome of patients with drug-induced autoimmune hepatitis

Digestive and liver disease, 2012-02, Vol.44, p.S12-S12

2012

Volltextzugriff (PDF)

T-6 Hyperuricemia is associated with severe steatosis in patients with chronic hepatitis C

Digestive and liver disease, 2012-02, Vol.44, p.S15-S15

2012

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(63)

Sprache

Englisch
(63)

Erscheinungsjahr

n.n

Kollektion

Ingenta
(63)
Elsevier ScienceDirect Journals Complete
(63)
IngentaConnect Journals
(26)
Journals@Ovid Full Text
(10)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(6)
Oxford Journals
(4)
Oxford Journals 2020 Medicine
(4)
MEDLINE
(1)

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

OC.03.2 ASSOCIATION OF VITAMIN D SERUM LEVELS AND ITS COMMON GENETIC DETERMINANTS, WITH SEVERITY OF LIVER FIBROSIS IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

OC.06.4: The Addition of an Immunosuppressant is an Effective Optimization Strategy after Loss of Response to Anti-Tnf Alpha Monotherapy in Patients with Inflammatory Bowel Disease: A Two-Year Experience

OC.06.5: Mycophenolate Mofetil is a Valid Option in Patients with Inflammatory Bowel Disease Resistant to TNF-Alpha Inhibitors and Conventional Immunosuppressants

P.11.3: Poor Tolerability Profile of Thiopurines in Inflammatory Bowel Disease: A Prospective Single-Centre Experience

P.11.15: The Long Term Course of Patients Undergoing Ileal Pouch-Anal Anastomosis for Ulcerative Colitis

P768 PNPLA3 rs738409 C>G SNP IS ASSOCIATED WITH HISTOLOGICAL FEATURES OF NASH IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

P1009 THE HISTOLOGICAL OR ULTRASONOGRAPHIC DETECTION OF STEATOSIS AFFECTS THE PERFORMANCE OF LIVER STIFFNESS MEASUREMENT FOR FIBROSIS ASSESSMENT IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 INFECTION

P0760 : PNPLA3 rs738409 I748M is associated with steatohepatitis in non obese subjects with hepatitis C

OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety

473 ASSOCIATION OF VITAMIN D SERUM LEVELS AND ITS COMMON GENETIC DETERMINANTS, WITH SEVERITY OF LIVER FIBROSIS IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

486 INDUSTRIAL, BUT NOT FRUIT FRUCTOSE INTAKE IS INDEPENDENTLY ASSOCIATED WITH SEVERE LIVER FIBROSIS IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

PNPLA3 RS738409 I748 M is associated with steatohepatitis in non obese subjects with hepatitis C

The histological or ultrasonographic detection of steatosis affects the performance of LSM in patients with chronic HCV genotype 1 infection

PNPLA3 rs738409 C > G SNP is associated with histological features of NASH in genotype 1 chronic hepatitis C patients

918 HIGH SCD36 PLASMA LEVEL IS ASSOCIATED WITH STEATOSIS AND ITS SEVERITY IN PATIENTS WITH CHRONIC GENOTYPE 1 HEPATITIS C

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

P.18.10 IL28-B POLYMORPHISMS AND NATURAL HISTORY OF PRIMARY BILIARY CIRRHOSIS

P.03.7 CLINICAL COURSE AND PROGNOSTIC FACTORS OF HEPATORENAL SYNDROME: THE IMPACT OF VASOACTIVE DRUGS

P.03.15 NATURAL HISTORY OF PRIMARY BILIARY CIRRHOSIS: EXPERIENCE FROM SINGLE CENTER IN SOUTHERN ITALY

T-03 Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients

F-06 Industrial, but not fruit fructose intake is independently associated with severe liver fibrosis in genotype 1 chronic hepatitis C patients

T-18 Natural history of primary biliary cirrhosis: experience from a single center in southern Italy

OC-34 Clinical features and outcome of patients with drug-induced autoimmune hepatitis

T-6 Hyperuricemia is associated with severe steatosis in patients with chronic hepatitis C

Suchergebnisse filtern